96 related articles for article (PubMed ID: 8404932)
1. Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction.
Young IS; Purvis JA; Lightbody JH; Adgey AA; Trimble ER
Eur Heart J; 1993 Aug; 14(8):1027-33. PubMed ID: 8404932
[TBL] [Abstract][Full Text] [Related]
2. The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction.
Ozmen D; Boydak B; Mutaf I; Zoghi M; Kumanlioğlu K; Güner I; Bayindir O
Jpn Heart J; 1999 May; 40(3):267-73. PubMed ID: 10506849
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction.
Ohlin H; Pavlidis N; Ohlin AK
Am J Cardiol; 1998 Dec; 82(12):1463-7. PubMed ID: 9874048
[TBL] [Abstract][Full Text] [Related]
4. Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
Longridge DJ; Follenfant MJ; Maxwell MP; Ford AJ; Hughes B
Cardiovasc Res; 1990 Sep; 24(9):697-706. PubMed ID: 2121357
[TBL] [Abstract][Full Text] [Related]
5. Dose-ranging study with a new two-chain rt-PA in patients with acute myocardial infarction: a multicenter trial.
DeWood MA; Kurnik PB; Jolly MK; Jain AC; Khaja F; Gorfinkel HJ; Morris DL; Satler L; LittleJohn J
Clin Cardiol; 1993 Apr; 16(4):302-10. PubMed ID: 8458110
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant status and lipid peroxidation in hereditary haemochromatosis.
Young IS; Trouton TG; Torney JJ; McMaster D; Callender ME; Trimble ER
Free Radic Biol Med; 1994 Mar; 16(3):393-7. PubMed ID: 8063202
[TBL] [Abstract][Full Text] [Related]
7. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
Longridge DJ; Follenfant MJ; Ford AJ
Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation associated with successful thrombolysis.
Davies SW; Ranjadayalan K; Wickens DG; Dormandy TL; Timmis AD
Lancet; 1990 Mar; 335(8692):741-3. PubMed ID: 1969508
[TBL] [Abstract][Full Text] [Related]
9. Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis: utility of assaying plasma malondialdehyde.
Pucheu S; Coudray C; Vanzetto G; Favier A; Machecourt J; de Leiris J
Free Radic Biol Med; 1995 Dec; 19(6):873-81. PubMed ID: 8582662
[TBL] [Abstract][Full Text] [Related]
10. The importance of early patency after acute myocardial infarction.
Grover A; Rihal CS
Curr Opin Cardiol; 1995 Jul; 10(4):361-6. PubMed ID: 7549077
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction.
Giardina B; Penco M; Lazzarino G; Romano S; Tavazzi B; Fedele F; Di Pierro D; Dagianti A
Am J Cardiol; 1993 Apr; 71(10):788-93. PubMed ID: 8456755
[TBL] [Abstract][Full Text] [Related]
12. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage.
Haider AW; Andreotti F; Hackett DR; Tousoulis D; Kluft C; Maseri A; Davies GJ
J Am Coll Cardiol; 1995 Sep; 26(3):662-7. PubMed ID: 7642856
[TBL] [Abstract][Full Text] [Related]
13. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
Malcolm AD; Keltai M; Walsh MJ
Eur Heart J; 1996 Oct; 17(10):1522-31. PubMed ID: 8909909
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients.
Wen Y; Killalea S; McGettigan P; Feely J
Ir J Med Sci; 1996; 165(3):210-2. PubMed ID: 8824028
[TBL] [Abstract][Full Text] [Related]
15. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
[TBL] [Abstract][Full Text] [Related]
16. Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
Ostermann H; Schmitz-Huebner U; Windeler J; Bär F; Meyer J; van de Loo J
Eur Heart J; 1992 Sep; 13(9):1225-32. PubMed ID: 1396833
[TBL] [Abstract][Full Text] [Related]
17. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
18. No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarction.
Olsson KA; Harnek J; Ohlin AK; Pavlidis N; Thorvinger B; Ohlin H
Scand Cardiovasc J; 2002 Aug; 36(4):237-40. PubMed ID: 12201972
[TBL] [Abstract][Full Text] [Related]
19. Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rate.
Huber K; Beckmann R; Probst P; Rauscha F; Kaindl F; Binder BR
Thromb Haemost; 1993 Jan; 69(1):45-9. PubMed ID: 8446938
[TBL] [Abstract][Full Text] [Related]
20. High frequency QRS electrocardiography in the detection of reperfusion following thrombolytic therapy.
Aversano T; Rudikoff B; Washington A; Traill S; Coombs V; Raqueno J
Clin Cardiol; 1994 Apr; 17(4):175-82. PubMed ID: 8187367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
